THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) ARC-EX System is the first and only FDA approved technology...
EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to integrating sustainable business practices EINDHOVEN, the Netherlands, Dec. 12, 2024...
Onward Opportunities Limited 06 December 2024 6 December 2024 Onward Opportunities Limited ("Onward Opportunities" or the "Company") Additional Subscription and Total Voting Rights ...
Onward Opportunities Limited 04 December 2024 The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU...
Onward Opportunities Limited 02 December 2024 2 December 2024 Onward Opportunities Limited ("Onward Opportunities" or the "Company") Net Asset Value Onward Opportunities Limited...
Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company’s top investor Signed exclusive license with CEA to develop and commercialize WIMAGINE...
Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke...
EINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to...
Onward Opportunities Limited 01 November 2024 1 November 2024 Onward Opportunities Limited ("Onward Opportunities" or the "Company") Net Asset Value Onward Opportunities Limited...
EINDHOVEN, the Netherlands, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 11 | 8.94308943089 | 123 | 134 | 123 | 15694 | 126.86172707 | DE |
4 | 12 | 9.83606557377 | 122 | 134 | 120 | 12501 | 123.90396399 | DE |
12 | 6 | 4.6875 | 128 | 134 | 119.5 | 20966 | 122.81026303 | DE |
26 | 10 | 8.06451612903 | 124 | 134 | 119.5 | 17735 | 122.84584421 | DE |
52 | 31.5 | 30.7317073171 | 102.5 | 134 | 101 | 17537 | 115.12760512 | DE |
156 | 37.5 | 38.8601036269 | 96.5 | 134 | 96.5 | 17511 | 110.12678334 | DE |
260 | 37.5 | 38.8601036269 | 96.5 | 134 | 96.5 | 17511 | 110.12678334 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales